Clinical trials should be considered at every stage of AML treatment. Clinical trials can provide earlier access to treatments you otherwise could not receive. Remember, today's treatments are yesterday's clinical trials.
AML News — October 21, 2021
Join us virtually via Zoom on October 28th at 2 PM Central to learn from Dr. Stein of Memorial Sloan Kettering Cancer Center about the importance of a personalized approach for treating your acute myeloid leukemia. Learn about what personalized medicine is, how it can improve your treatment outcomes and the importance of being cared for by an AML specialist. Come with your questions and comments!
AML Clinical Trials—October 11, 2021
The combination of ficlatuzumab and cytarabine could provide an alternative therapeutic option for patients with relapsed or refractory AML that has already shown positive results in an early clinical trial.
Life with AML—October 11, 2021
Men are caregivers too! Actually, about 40% of caregivers are men. It's time we include men in the conversation and provide them with the support and resources they need in order to care for their loved ones with AML. Join our AML caregivers Facebook group and AML caregivers chapter to give and receive support. Links in article!
AML News—October 8, 2021
The AML research community is making gains on how to best treat AML based on the unique genetic mutations each patient has. FLT3, IDH1, IDH2 and NPM1 are all types of AML mutations that are currently receiving quite a bit of research attention. Learn more about these specific mutations and what it may mean for your treatment regimen.
Childhood AML—October 5, 2021
Researchers at St. Jude’s Research Hospital have found that mapping the genome of pediatric cancer patients can help give precision care to those with a cancer diagnosis like AML. Because AML looks and behaves differently from child to child, tumor sequencing can give guidance in making overall treatment decisions that are unique to each patient.
Life with AML—October 4, 2021
Kenny Hall recounts the experience of his life saving allogeneic stem cell transplant in 2012 at MD Anderson in Houston, Texas. You can read additional posts about his AML experience on his blog at www.cancersportsfaith.wordpress.com